<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00799422</url>
  </required_header>
  <id_info>
    <org_study_id>M-08-02</org_study_id>
    <nct_id>NCT00799422</nct_id>
  </id_info>
  <brief_title>Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients</brief_title>
  <official_title>Evaluation of Lens Fit, Lens Parameters, and Circumlimbal Conjunctival Staining (CSS) in Normal Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate contact lens fit, lens parameters, and
      conjunctival staining in a sample of subjects with various contact lens/solution
      combinations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Circumlimbal Conjunctival Staining Score</measure>
    <time_frame>1 week</time_frame>
    <description>Circumlimbal conjunctival staining was expressed as the sum of the individual scores observed across all of the evaluated regions of the eye. The bulbar conjunctiva was assessed by the investigator utilizing a slit-lamp and lissamine green ophthalmic dye. Staining coverage was scored separately in each of four regions (nasal, temporal, inferior, and superior) using a 4-point clinical grading scale (grade 0-3), where Grade 0 = No staining present; Grade 1 = Slight staining present; Grade 2 = Moderate staining present; and Grade 3 = Dense staining present. The scores for the four regions were summed, with a sum score range of 0-12. A lower score represents a more desirable outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Change From Dispense (Day 0) in Lens Base Curve at 1 Week</measure>
    <time_frame>Dispense (Day 0), 1 week</time_frame>
    <description>Lens base curve at dispense was as listed on product label: 8.4 millimeters (mm). Lens base curve at 1 week was as measured after lens removal. A negative number represented a steepening of the base curve.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change From Dispense (Day 0) in Lens Diameter at 1 Week</measure>
    <time_frame>Dispense (Day 0), 1 week</time_frame>
    <description>Lens diameter at dispense was as listed on product label: 14.0 mm. Lens diameter at 1 week was as measured after lens removal. A positive number indicated a widening of lens diameter.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Conjunctival Staining</condition>
  <arm_group>
    <arm_group_label>ReNu MultiPlus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ReNu MultiPlus used as specified in the protocol for contact lens care. In this crossover study, ReNu MultiPlus was dispensed in randomized order with Complete Easy Rub and Clear Care. Each product was used for one week with a fresh pair of Acuvue Oasys contact lenses. A 36-hour washout preceded each usage period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Complete Easy Rub</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Complete Easy Rub used as specified in the protocol for contact lens care. In this crossover study, Complete Easy Rub was dispensed in randomized order with ReNu MultiPlus and Clear Care. Each product was used for one week with a fresh pair of Acuvue Oasys contact lenses. A 36-hour washout preceded each usage period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clear Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clear Care used as specified in the protocol for contact lens care. In this crossover study, Clear Care was dispensed in randomized order with Complete Easy Rub and ReNu MultiPlus. Each product was used for one week with a fresh pair of Acuvue Oasys contact lenses. A 36-hour washout preceded each usage period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Complete Easy Rub</intervention_name>
    <description>Commercially marketed contact lens solution for contact lens care</description>
    <arm_group_label>Complete Easy Rub</arm_group_label>
    <other_name>Complete® Easy Rub®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReNu MultiPlus</intervention_name>
    <description>Commercially marketed contact lens solution for contact lens care</description>
    <arm_group_label>ReNu MultiPlus</arm_group_label>
    <other_name>ReNu MultiPlus®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clear Care</intervention_name>
    <description>Commercially marketed contact lens solution for contact lens care</description>
    <arm_group_label>Clear Care</arm_group_label>
    <other_name>Clear Care®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Contact lenses</intervention_name>
    <description>Acuvue Oasys silicone hydrogel contact lenses per participant's habitual prescription worn 8-10 hours per day for one week.</description>
    <arm_group_label>ReNu MultiPlus</arm_group_label>
    <arm_group_label>Complete Easy Rub</arm_group_label>
    <arm_group_label>Clear Care</arm_group_label>
    <other_name>ACUVUE® OASYS®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Successfully wearing hydrogel and/or silicone hydrogel contact lenses;

          -  Read, sign, and date informed consent/HIPAA document;

          -  Vision correctable to 20/30 (Snellen) or better in each eye at distance with habitual
             spectacles;

          -  Willing and able to discontinue contact lens wear when requested during the study;

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Evidence or history of ocular disease or pathology;

          -  One functional eye or a monofit lens;

          -  Use of concomitant topical ocular prescription or over-the-counter ocular medications;

          -  History of seasonal allergies with significant ocular side effects which may have an
             adverse impact on contact lens wear;

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alison Ramsey, O.D.</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 25, 2008</study_first_submitted>
  <study_first_submitted_qc>November 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2008</study_first_posted>
  <results_first_submitted>October 16, 2012</results_first_submitted>
  <results_first_submitted_qc>November 14, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 16, 2012</results_first_posted>
  <last_update_submitted>November 14, 2012</last_update_submitted>
  <last_update_submitted_qc>November 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Conjunctival Staining</keyword>
  <keyword>lens parameters</keyword>
  <keyword>lens fit</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contact Lens Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>In this 3-treatment, 3-period, 6-sequence crossover study, each subject received all 3 products in randomized order and used 1 product at a time for a duration of 1 week before switching to the next assigned product. A 36-hour washout preceded each usage period.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ReNu / Complete / Clear Care</title>
          <description>ReNu Multiplus, then Complete Easy Rub, then Clear Care, 1 week each</description>
        </group>
        <group group_id="P2">
          <title>Complete / Clear Care / ReNu</title>
          <description>Complete Easy Rub, then Clear Care, then ReNu MultiPlus, 1 week each</description>
        </group>
        <group group_id="P3">
          <title>Clear Care / ReNu / Complete</title>
          <description>Clear Care, then ReNu MultiPlus, then Complete Easy Rub, 1 week each</description>
        </group>
        <group group_id="P4">
          <title>ReNu / Clear Care / Complete</title>
          <description>ReNu MultiPlus, then Clear Care, then Complete Easy Rub, 1 week each</description>
        </group>
        <group group_id="P5">
          <title>Complete / ReNu / Clear Care</title>
          <description>Complete Easy Rub, then ReNu MultiPlus), then Clear Care, 1 week each</description>
        </group>
        <group group_id="P6">
          <title>Clear Care / Complete / ReNu</title>
          <description>Clear Care, then Complete Easy Rub, then ReNu MultiPlus, 1 week each</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Week of Wear</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Week of Wear</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3">One subject discontinued between First and Second 3 weeks (adverse event)</participants>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4">One subject discontinued between First and Second 3 weeks (adverse event)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Third Week of Wear</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>Baseline characteristics are presented for all participants completing all three treatment sequences.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.6" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Circumlimbal Conjunctival Staining Score</title>
        <description>Circumlimbal conjunctival staining was expressed as the sum of the individual scores observed across all of the evaluated regions of the eye. The bulbar conjunctiva was assessed by the investigator utilizing a slit-lamp and lissamine green ophthalmic dye. Staining coverage was scored separately in each of four regions (nasal, temporal, inferior, and superior) using a 4-point clinical grading scale (grade 0-3), where Grade 0 = No staining present; Grade 1 = Slight staining present; Grade 2 = Moderate staining present; and Grade 3 = Dense staining present. The scores for the four regions were summed, with a sum score range of 0-12. A lower score represents a more desirable outcome.</description>
        <time_frame>1 week</time_frame>
        <population>This reporting group includes all participants who completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>ReNu MultiPlus</title>
            <description>ReNu MultiPlus used for one week as specified in the protocol with study contact lenses.</description>
          </group>
          <group group_id="O2">
            <title>Complete Easy Rub</title>
            <description>Complete Easy Rub used for one week as specified in the protocol with study contact lenses.</description>
          </group>
          <group group_id="O3">
            <title>Clear Care</title>
            <description>Clear Care used for one week as specified in the protocol with study contact lenses.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Circumlimbal Conjunctival Staining Score</title>
          <description>Circumlimbal conjunctival staining was expressed as the sum of the individual scores observed across all of the evaluated regions of the eye. The bulbar conjunctiva was assessed by the investigator utilizing a slit-lamp and lissamine green ophthalmic dye. Staining coverage was scored separately in each of four regions (nasal, temporal, inferior, and superior) using a 4-point clinical grading scale (grade 0-3), where Grade 0 = No staining present; Grade 1 = Slight staining present; Grade 2 = Moderate staining present; and Grade 3 = Dense staining present. The scores for the four regions were summed, with a sum score range of 0-12. A lower score represents a more desirable outcome.</description>
          <population>This reporting group includes all participants who completed all study visits.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.39" spread="2.30"/>
                    <measurement group_id="O2" value="5.55" spread="2.94"/>
                    <measurement group_id="O3" value="5.68" spread="1.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change From Dispense (Day 0) in Lens Base Curve at 1 Week</title>
        <description>Lens base curve at dispense was as listed on product label: 8.4 millimeters (mm). Lens base curve at 1 week was as measured after lens removal. A negative number represented a steepening of the base curve.</description>
        <time_frame>Dispense (Day 0), 1 week</time_frame>
        <population>This reporting group includes all participants who completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>ReNu MultiPlus</title>
            <description>ReNu MultiPlus used for one week as specified in the protocol with study contact lenses.</description>
          </group>
          <group group_id="O2">
            <title>Complete Easy Rub</title>
            <description>Complete Easy Rub used for one week as specified in the protocol with study contact lenses.</description>
          </group>
          <group group_id="O3">
            <title>Clear Care</title>
            <description>Clear Care used for one week as specified in the protocol with study contact lenses.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Dispense (Day 0) in Lens Base Curve at 1 Week</title>
          <description>Lens base curve at dispense was as listed on product label: 8.4 millimeters (mm). Lens base curve at 1 week was as measured after lens removal. A negative number represented a steepening of the base curve.</description>
          <population>This reporting group includes all participants who completed all study visits.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.25" spread="0.16"/>
                    <measurement group_id="O2" value="-0.27" spread="0.17"/>
                    <measurement group_id="O3" value="-0.25" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change From Dispense (Day 0) in Lens Diameter at 1 Week</title>
        <description>Lens diameter at dispense was as listed on product label: 14.0 mm. Lens diameter at 1 week was as measured after lens removal. A positive number indicated a widening of lens diameter.</description>
        <time_frame>Dispense (Day 0), 1 week</time_frame>
        <population>This reporting group includes all participants who completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>ReNu MultiPlus</title>
            <description>ReNu MultiPlus used for one week as specified in the protocol with study contact lenses.</description>
          </group>
          <group group_id="O2">
            <title>Complete Easy Rub</title>
            <description>Complete Easy Rub used for one week as specified in the protocol with study contact lenses.</description>
          </group>
          <group group_id="O3">
            <title>Clear Care</title>
            <description>Clear Care used for one week as specified in the protocol with study contact lenses.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Dispense (Day 0) in Lens Diameter at 1 Week</title>
          <description>Lens diameter at dispense was as listed on product label: 14.0 mm. Lens diameter at 1 week was as measured after lens removal. A positive number indicated a widening of lens diameter.</description>
          <population>This reporting group includes all participants who completed all study visits.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.10"/>
                    <measurement group_id="O2" value="0.13" spread="0.11"/>
                    <measurement group_id="O3" value="0.14" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected for the duration of the study.</time_frame>
      <desc>This reporting group includes all enrolled and exposed participants.</desc>
      <group_list>
        <group group_id="E1">
          <title>ReNu MultiPlus</title>
          <description>ReNu MultiPlus used for one week as specified in the protocol with study contact lenses.</description>
        </group>
        <group group_id="E2">
          <title>Complete Easy Rub</title>
          <description>Complete Easy Rub used for one week as specified in the protocol with study contact lenses.</description>
        </group>
        <group group_id="E3">
          <title>Clear Care</title>
          <description>Clear Care used for one week as specified in the protocol with study contact lenses.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <description>Unrelated to study procedures or study products</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Head, Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

